ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,548 | -5.7% | 4,424 | +2.5% | 0.00% | – |
| Q2 2023 | $6,947 | -47.8% | 4,315 | -6.0% | 0.00% | – |
| Q1 2023 | $13,307 | -15.7% | 4,589 | -1.4% | 0.00% | – |
| Q4 2022 | $15,792 | +426.4% | 4,655 | +447.0% | 0.00% | – |
| Q3 2022 | $3,000 | -57.1% | 851 | -2.0% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 868 | +15.0% | 0.00% | – |
| Q1 2022 | $7,000 | -50.0% | 755 | -14.0% | 0.00% | – |
| Q4 2021 | $14,000 | +27.3% | 878 | +36.8% | 0.00% | – |
| Q3 2021 | $11,000 | -47.6% | 642 | -50.3% | 0.00% | – |
| Q2 2021 | $21,000 | +10.5% | 1,291 | -5.4% | 0.00% | – |
| Q1 2021 | $19,000 | -96.8% | 1,365 | -95.6% | 0.00% | -100.0% |
| Q4 2020 | $602,000 | +78.1% | 30,703 | +17.7% | 0.00% | +100.0% |
| Q3 2020 | $338,000 | +8350.0% | 26,090 | +7573.5% | 0.00% | – |
| Q2 2020 | $4,000 | -50.0% | 340 | -63.0% | 0.00% | – |
| Q1 2020 | $8,000 | – | 920 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,576,000 | 23.33% |
| Antipodean Advisors LLC | 1,000,000 | $15,760,000 | 6.47% |
| M28 Capital Management LP | 456,865 | $7,200,000 | 5.62% |
| Redmile Group, LLC | 6,437,777 | $101,459,000 | 2.31% |
| One Fin Capital Management LP | 303,000 | $4,775,000 | 1.99% |
| MAVERICK CAPITAL LTD | 7,855,824 | $123,808,000 | 1.40% |
| Baupost Group | 8,477,488 | $133,605,000 | 1.32% |
| BRIDGER MANAGEMENT, LLC | 616,488 | $9,716,000 | 1.26% |
| 683 Capital Management, LLC | 1,781,234 | $28,073,000 | 1.03% |
| Trellus Management Company, LLC | 95,000 | $1,497,000 | 1.00% |